ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Parvus and Genentech to develop treatment options in gastroenterology pharmaceutical-technology
May 22, 2019Biopharmaceutical firm Parvus Therapeutics has signed a worldwide collaboration and licence agreement with Genentech to develop, manufacture and commercialise therapeutics?for inflammatory bowel disease (IBD), autoimmune liver diseases (ALD) and?coeliac d
Pharma Sources Insight January 2025
